COA Verification Checklist for RUO Peptides – Lab QA Guide
In research laboratories, a peptide’s Certificate of Analysis (COA) is the authoritative batch-specific report of analytical test results. It shows key quality attributes like molecular identity and purity for that synthesis batch. For research-use-only (RUO) peptides, the COA is used solely to confirm the peptide matches its description and meets lab-grade standards (without any medical or diagnostic claims).
Fast Answer
Products discussed in this article are intended for laboratory research use only and are not intended for human or animal consumption. Researchers should verify a peptide COA by confirming the sequence/identity (e.g. by mass spectrometry【53†L933-L942】【40†L600-L609】) and ensuring reported purity (via analytical HPLC【12†L217-L224】) and peptide content【17†L40-L47】 meet expectations. This checklist approach covers identity confirmation, purity and net peptide content measurement, and proper documentation of analytical methods and RUO labeling.
Peptide COA Overview
A peptide Certificate of Analysis is a formal quality-control document for one batch of material. It typically lists the peptide name/sequence, lot number, and test results such as molecular weight (identity confirmation) and purity percentage. Regulatory guidelines note that identity tests should be highly specific (e.g. mass spectrometry or spectroscopy) rather than relying on a single HPLC retention time【40†L600-L609】【53†L933-L942】. Thus a COA provides a “snapshot” of key analytical tests run on that peptide lot for researchers.
Verifying Peptide Identity
Identity confirmation involves matching the peptide’s measured mass or composition to its expected sequence. EMA guidance recommends using two orthogonal methods (for example LC-MS plus HPLC retention time) to confirm peptide identity【53†L933-L942】【40†L600-L609】. On the COA, check that the measured mass (m/z) matches the theoretical mass of the peptide formula. Amino acid analysis or NMR may also support identity, but mass-based methods are most common. If the COA’s identity data do not match the expected sequence, the batch should be considered incorrect.
Assessing Purity and Peptide Content
Purity is typically reported as a percentage via reverse-phase HPLC. It represents the area of the main peptide peak relative to all peaks【12†L217-L224】【53†L945-L954】. The COA will usually list a purity (for example ≥95%). Net peptide content (NPC) is reported separately: it measures the fraction of the vial that is actual peptide (excluding salts, counter-ions, or moisture)【12†L256-L264】【17†L40-L47】. NPC is often lower than purity. For example, a peptide can be 100% pure (single HPLC peak) but only 70% NPC if the remaining weight is TFA or water.
Additional Quality Parameters
COAs may include other analytical tests. Residual solvents (from synthesis) are checked by gas chromatography, and should be below pharmacopoeial limits. Water content is measured by Karl Fischer titration. Counter-ions (e.g. TFA, acetate) may be quantified by ion chromatography. Some COAs include endotoxin testing if needed for cell-based assays. Although RUO peptides are not intended for injection, knowing low endotoxin levels is important for sensitive in vitro work.
COA Documentation and RUO Labeling
Each COA should be clearly lot-specific and dated. It generally includes the peptide name/sequence, net weight, form (salt form, lyophilized, etc.), lot number, release date, and the QC analyst or laboratory that performed the tests. Importantly, RUO peptides must be labeled “For Research Use Only” and note they are not for human or animal use【36†L185-L193】. Verify that the COA’s lot number matches the product label. Any mismatches in lot code or missing RUO disclaimers should be resolved with the supplier before using the peptide.
COA Verification Checklist
| COA Item | Verification Criteria |
| Identity (Molecular Weight) | Ensure the COA’s MS or sequencing result matches the expected peptide mass/formula【53†L933-L942】【40†L600-L609】. |
| Purity | Check HPLC purity. The main peak percentage should meet the specification (typically ≥95%)【12†L217-L224】【53†L945-L954】. |
| Net Peptide Content | Verify the NPC (from AAA or nitrogen analysis) is consistent with purity. NPC excludes salts and moisture and is usually lower【12†L256-L264】【17†L40-L47】. |
| Residuals & Moisture | Review reported levels of residual solvents, counter-ions, and water. These should be minimal and chemically plausible for the peptide. |
| Analytical Methods | Confirm the COA lists analytical methods (e.g. LC-MS, HPLC, AAA). At least two orthogonal methods for identity/purity are recommended【53†L933-L942】. |
| Labeling and Documentation | Ensure the COA includes lot number, date, and “RUO” disclaimers【36†L185-L193】. The product label must match the COA’s batch, and the COA should be signed or approved. |
COA Verification Workflow
Use this step-by-step flowchart to review each peptide COA:
FAQs
What information does a peptide COA provide?
A COA provides batch-specific analytical data for a peptide. It typically lists the peptide sequence or chemical name, measured molecular weight (identity), purity percentage (from HPLC), net peptide content, and results of any impurity or residual tests. It also includes the lot number, release date, and the analytical methods used. Researchers use the COA to confirm that the peptide’s composition matches its label and meets quality criteria【53†L933-L942】【12†L256-L264】.
How is peptide identity confirmed on a COA?
Peptide identity is confirmed by analytical tests like mass spectrometry. The COA should show that the measured mass matches the expected mass of the sequence. Often an orthogonal check (e.g. LC-MS/MS fragmentation or HPLC co-elution with a reference) is also used. Regulatory guidance recommends using at least two methods for identity (for example, LC-MS plus a secondary retention-time check)【53†L933-L942】【40†L600-L609】. If the COA’s identity data do not match, the batch should not be used.
What is the difference between purity and net peptide content?
Purity is the percentage of the desired peptide in the sample as measured by HPLC【12†L217-L224】. Net peptide content (NPC) is the fraction of the total weight that is actual peptide (excluding water, salts, and counter-ions)【12†L256-L264】【17†L40-L47】. In other words, a peptide might be 100% pure (only one peak) but have, say, 70% NPC if 30% of the weight is counter-ions or moisture. Both values are important for accurate solution preparation.
Should I trust a COA from any supplier?
A COA is only reliable if it comes from a reputable source. Ensure the COA is signed and specific to the lot you received. Check that complete analytical data (MS, HPLC, etc.) are included and values are reasonable. Incomplete or inexplicable COAs (e.g. very high purity with inconsistent NPC) warrant caution. If in doubt, consider third-party verification or choose suppliers with transparent quality records.
What if COA details seem inconsistent?
If reported values conflict or key tests are missing, contact the supplier for clarification or additional data. Do not use the peptide until discrepancies are resolved. Reputable suppliers will provide raw chromatograms or spectra if needed. It’s acceptable to request an updated COA or independent testing to ensure the peptide’s quality before proceeding with research.
Why is RUO labeling important on a COA?
RUO labeling indicates the peptide is meant strictly for research, not for diagnostic or therapeutic use【36†L185-L193】. The COA and product label should clearly state “For Research Use Only.” This prevents misuse in clinical settings and aligns with regulatory guidance. Always check for RUO disclaimers to ensure the peptide meets RUO compliance and to avoid any confusion about its intended use.
Next Steps
Review batch-specific documentation before selecting any research-use-only peptide. Explore Pure Lab Peptides for RUO peptide compounds with clear labeling, research-focused product information, and available documentation. When comparing suppliers, prioritize those with transparent COAs and complete lot-level data as key quality indicators.
References
- European Medicines Agency. “Guideline on the Development and Manufacture of Synthetic Peptides.” EMA Scientific Guideline. 2023. ema.europa.eu
- International Conference on Harmonisation. “Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and Products (Q6A).” 2000. database.ich.org
- Bachem. “Quality Control of Amino Acids & Peptides: A Guide.” Bachem Knowledge Center. 2024. bachem.com/knowledge-center/quality-control-of-amino-acids-peptides-a-guide
- AmbioPharm. “What is net peptide content?” AmbioPharm (FAQ). 2024. ambiopharm.com/faq/what-is-net-peptide-content
- Johner Institute. “Laboratory products for “Research Use Only” (RUO) – often a dangerous claim.” Johner Institute. 2026. johner-institute.com/regulatory-affairs/for-research-use-only-ruo